NL2029421B1 - Ultramarine fluorescent protein, construction method therefor and use thereof in preparation of protein sunscreen agent - Google Patents

Abstract

The present disclosure belongs to the field of protein construction, in particular to an ultramarine fluorescent protein and its construction method and use thereof in preparation of protein sunscreen agent, and further relates to a sunscreen agent containing the ultramarine fluorescent protein. An ultramarine fluorescent protein, is a protein selected from (a) and (b) protein: (a) a protein consisting of an amino acid sequence set forth in SEQ IDzNO. 2; (b) a protein derived from (a) by substitution, deletion or addition with one or more amino acids in the amino acid sequence of (a) and having activity of the ultramarine fluorescent protein. The ultramarine fluorescent protein (UFP) has the characteristics of pH-insensitivity and light stability, and its chromophore can absorb long-wavelength ultraviolet (UVA) and release fluorescence at wavelength longer than 400 nm. And the aromatic amino acids residue (with content of 9.2%) can absorb medium wavelength ultraviolet (UVB) and release UVA. UVA can be further absorbed by chromophore by resonance energy transfer. UFP is possibility to be developed as a protein sunscreen.

Description

ULTRAMARINE FLUORESCENT PROTEIN, CONSTRUCTION METHOD

THEREFOR AND USE THEREOF IN PREPARATION OF PROTEIN

SUNSCREEN AGENT

TECHNICAL FIELD

[01] The present disclosure belongs to the field of protein construction, in particular relates to an ultramarine fluorescent protein and its construction method and use thereof in preparation of protein sunscreen agent, and further relates to a sunscreen agent containing the ultramarine fluorescent protein.

BACKGROUND ART

[02] In the early 1960s, Shimomura isolated a green fluorescent protein (GFP) from jellyfish for the first time, which is stable at high temperature (T=78 C)!*!. Fluorescent protein (FP) is a kind of protein that can be excited by specific wavelength light to produce fluorescence, and the amino acid residues at positions 65, 66 and 67 forming chromophore'?!. The optical properties of the chromophores are formed by autocatalysis of a tripeptide (residues at 65-67) covalently bound to the central a-helix and buried in a B-barrel structure *. The formation of aromatic amino acids and 1midazolinone groups at position 66 is closely related to the conjugation of the chromophores and their broad-spectrum properties, the mutation of amino acids at position 66 into aromatic amino acids such as tyrosine, phenylalanine, tryptophan or histidine strongly affects the optical spectrum 1. A blue fluorescent protein (ultramarine fluorescent protein, UFP1, with an excitation peak at 355 nm and an emission peak at 424 nm) is obtained by the GFP-Phe66 mutation, but its quantum yield is low 1. An ultramarine fluorescent protein, named Sirius, is obtained after further mutation of UFP1 at positions T65Q, Y145G, H148S and T203V, and its brightness is 80 folds brighter than that of mseCFP-W66FP!. At present, this protein is mainly used in cell imaging !®!, fluorescent probe 7! and so on.

[03] In view of the damage of ultraviolet to the skin and the increasing awareness of ultraviolet protection, people need safer and more efficient sunscreens, and the research and development on new sunscreens has become an important research direction for many researchers. At present, the sunscreens in sunscreen products on the market are mainly chemical absorbents and physical shielding agents, some chemical absorbents will undergo decomposition upon long-time UV exposure, produce free radicals or intermediate products harmful to the human body !9:! or penetrate into skin due to the small molecular weight 21. The main physical shielding agents are

TiO; and ZnO. With the development of nano-sunscreens, such sunscreens are often prepared into insoluble particles with a diameter of less than 100 nm. However, many studies have reported that these particles are too small and can easily penetrate the skin and enter the blood causing harmful effect to human body !** Bioengineering sunscreens (such as epidermal growth factor, superoxide dismutase, etc.) are UV protection products developed using bioengineering technology. Their UV protection effect is mainly achieved by regulating the immune function of skin, increasing cell activity, resisting and repairing radiation damage, thereby strengthening the protection effect of chemical sunscreens, and playing an auxiliary and synergistic role. However, there are no related reports about protein used as the major sunscreen agent 8.

[04] The aromatic amino acids in protein are capable of absorbing UVB, wherein tyrosine has an absorption peak at 275 nm, and the fluorescence released at 305 nm can be absorbed by tryptophan (absorption peak is at 295 nm), which releases fluorescence at about 353 nm. The proportion of aromatic amino acids in UFP is 9.2%, which can absorb a certain amount of UVB and release UVA fluorescence, while the chromophore (absorption peak is at 355nm) in UFP can absorb the released fluorescence through resonance energy transfer (FIG. 1). Therefore, UFP can theoretically absorb UVA and UVB and release fluorescence with a wavelength longer than 400 nm, which is harmless to the human body. In order to explore sunscreen formulated with proteins, UFP is purified by prokaryotic expression and affinity-purification. In order to improve its purification efficiency, heating treatment combined with an organic solvent extraction method is established to purify the fluorescent proteins. In order to detect its ability to absorb UV light, the anti-ultraviolet ability is analyzed using Escherichia coli over expressing the UFP, and its optical characteristics are also analyzed by ultraviolet absorption spectrum and UFP fluorescence spectrum. In order to explore its toxicity to cells, MTT assay is used to analyze the influence of UFP on the growth of TL-OML cells. This study has laid a good foundation for further exploration of the feasibility of UFP as a sunscreen and developmental of safe and broad-spectrum sunscreen products.

SUMMARY OF THE INVENTION

[05] In order to solve the above technical problems, the first objective of the present disclosure is to provide an ultramarine fluorescent protein, the second objective is to provide a gene encoding the above ultramarine fluorescent protein, and the third objective is to provide a construction method for the above ultramarine fluorescent protein, the fourth objective is to provide the use of the above ultramarine fluorescent protein.

[06] Furthermore, the present disclosure provides

[07] An ultramarine fluorescent protein, wherein the ultramarine fluorescent protein is a protein selected from (a) and (b):

[08] (a) a protein consisting of an amino acid sequence set forth in SEQ ID:NO. 2;

[09] (b) a protein derived from (a) by substitution, deletion or addition with one or more amino acids in the amino acid sequence of (a) and having activity of the ultramarine fluorescent protein.

[10] Furthermore, the disclosure also provides a gene encoding the above ultramarine fluorescent protein.

[11] In some embodiments, the nucleotide sequence of the gene is the DNA molecule set forth in SEQ ID: NO. 1.

[12] Furthermore, the disclosure also provides a vector containing the gene.

[13] Furthermore, the disclosure also provides a transformant containing the vector.

[14] Furthermore, the disclosure also provides a method for constructing the above ultramarine fluorescent protein, which comprises the following steps:

[15] 1) obtaining DNA molecules by using PCR site-directed mutagenesis : carrying out PCR site-directed mutagenesis by using mutation primers based on F46L, T65Q,

WOOF, Q69L, Y145G, H148S and T203V sites, with pETCFP-CI as a template;

[16] 2) transforming the obtained DNA molecules into DH5a, and obtaining the gene-mutated UFP after bacteria selection and sequencing;

[17] 3) double enzyme digesting pETUFP-CI, and expression vectors pET-24a and pHND by restriction enzymes BamH I/EcoR 1, respectively, and then ligating to construct a pET-24a-UFP vector and a pHND-UFP expression vector for expressing

UFP;

[18] 4) transforming a mutated plasmid into BL21(DE3), culturing overnight in liquid media, inoculating and further culturing to ODsoo of 0.5, adding IPTG to induce protein expression for 3 h and collecting the bacteria;

[19] 5) suspending the bacteria pellet in the lysisbuffer, breaking the bacteria by ultrasonication in an ice bath, centrifugating and collecting a supernatant;

[20] ©) heating the supernatant, extracting the supernatant with an organic solvent, and then dialyzing the supernatant to remove impurities, concentrating the protein by low-speed centrifugation in a 3 kD ultrafiltration tube, determining concentration of the UFP protein according to a Bradford technique.

[21] Furthermore, the disclosure also provides a mutation primer sequence in the method, and the sequence of the mutation primers for PCR are as follows:

[22] F46L-F: GACCCTGAAGCTGATCTGCACCACCG

[23] F46L-R: CGGTGGTGCAGATCAGCTTCAGGGTC

[24] T65Q-W66F-F: GTGACCACCCTGCAGTTTGGCGTGCAGTGC

[25] T65Q-W66F-R: GAAGCACTGCACGCCAAACTGCAGGGTGGTCACGAG

[26] Q69L-F: GTTTGGCGTGCTGTGCTTCAGCC

[27] Q69L-R: GGCTGAAGCACAGCACGCCAAAC

[28] Y145G-H148S-F:

GCTGGAGTACAACGGCATCAGCAGCAACGTCTATATCACC

[29] Y145G-H148S-R:

GGTGATATAGACGTTGCTGCTGATGCCGTTGTACTCCAGCTTG

[30] T203V-F: CCACTACCTGAGCGTGCAGTCCGCC 5 [BIJ T203V-R: GCTCAGGGCGGACTGCACGCTCAGGTAGTGGTTG

[32] Furthermore, the disclosure also provides the use of the ultramarine fluorescent protein in preparation of protein sunscreen agent.

[33] Furthermore, the disclosure also provides a protein sunscreen agent comprising the ultramarine fluorescent protein.

[34] Due to the adoption of the above-mentioned technical scheme, the ultramarine fluorescent protein (UFP) provided by the present disclosure has the characteristics of pH-insensitivity and light stability, whose chromophore can absorb long-wavelength ultraviolet (UVA) and release fluorescence at wavelength longer than 400 nm. At the same time the aromatic amino acids content is high (9.2%), which can absorb medium wavelength ultraviolet (UVB) and release UVA. UVA can be further absorbed by chromophores through resonance energy transfer, therefore UFP is possible to be developed as a protein sunscreen. UFP is obtained by PCR site-directed mutagenesis, prokaryotic expression, and affinity-purification. A rapid purification method for fluorescent proteins is established by using heating treatment combined with organic solvent extraction. The ability of UFP to absorb ultraviolet is preliminarily analyzed by corresponding spectra and survival experiments after ultraviolet irradiation on E. coli.

The toxicity of UFP to cells is analyzed by MTT assay. The results show that the UFP (purity >94.7%) can be purified quickly by heating the supernatant (after the bacteria was broken) at 70 °C for 10 min combined with organic solvent extraction. This method is also applicable to other fluorescent proteins. The ultraviolet absorption spectrum shows that UFP has a certain absorption of ultraviolet rays with a wavelength of 250-400 nm, and the absorption peaks are at 280 nm (£max280 is 3.27x10* Mem!) and 365 nm (maxes is 1.5410% M"?-cm!). The fluorescence spectrum shows that UFP absorbs ultraviolet with a wavelength of

250-400 nm and releases fluorescence longer than 400 nm. The survival experiments of £. coli after ultraviolet irradiation shows that the expression of UFP in £. coli can improve the ability of the strain to resist ultraviolet irradiation. The analysis of MTT assay on toxicity shows that UFP (concentration <5 M) has little effect on growth of

TL-OML cell strain. UFP is stable in nature, has an ability to absorb UVB and UVA, does not have toxic effect on cells, and can be used as a broad-spectrum sunscreen agent. The results lay a certain foundation for in-depth study on the use of protein to develop sunscreens.

BRIEF DESCRIPTION OF THE DRAWINGS

[35] FIG. 1 briefly shows the structure of the ultramarine fluorescent protein and its principle of absorbing ultraviolet. The fluorescent chromophore (blue group in the tigure) of ultramarine fluorescent protein (UFP) can absorb ultraviolet in UVA, with the maximum absorption peak being at 365 nm, and release fluorescence at a wavelength longer than 400 nm. The aromatic amino acids (red-labeled amino acids) can absorb ultraviolet in UVB, and the released fluorescence lies at 310-350 nm, which can be absorbed by UFP fluorescent chromophores (the distance between them is less than 10 nm, which is within the range of FRET). This protein will have the ability of absorbing UVA and UVB.

[36] FIG.2 shows the electrophoresis diagram of results for purification and enzymatic digestion of the Hal2-UFP fusion protein (M. Protein Marker; 1. HAL2-

UFP after PAP column purification; 2. HAL2-UFP after enzymatic digestion; 3. HAL2 tag removed after enzymatic digestion).

[37] FIG. 3 shows the UFP purification method comparison between the extraction by organic solvents and the combination of organic solvents and heating (M. Protein

Marker; 1. £. coli before IPTG induction; 2. £. coli after IPTG induction; 3.

Supernatant collected after cell disruption and centrifugation; 4. Sample of ethanol phase after ethanol extraction; 5. Sample of aqueous phase after n-butanol extraction; 6.

Supernatant after heating; 7. Sample of ethanol phase after heating followed by ethanol extraction; 8. Sample of aqueous phase after heating followed by n-butanol extraction).

[38] FIG. 4 shows electrophoresis diagrams of different fluorescent proteins purified by heating combined with organic solvent extraction (M. Protein Marker; 1. Red fluorescent protein (RFP) obtained after heating and extraction; 2. supernatant containing RFP after cell disruption and centrifugation; 3. Cyan fluorescent protein (CFP) obtained after heating and extraction; 4. supernatant containing CFP after cell disruption and centrifugation; 5. Yellow fluorescent protein (YFP) obtained after heating and extraction; 6. supernatant containing YFP after cell disruption and centrifugation; 7. Green fluorescent protein (GFP) obtained after heating and extraction, 8. supernatant containing GFP after cell disruption and centrifugation).

[39] FIG. 5 is a diagram showing the anti-ultraviolet results of F. coli after UFP expression in vivo.

[40] FIG. 6 shows the UV absorption spectrum of UFP.

[41] FIG. 7A shows the fluorescence spectrum of Hal2-UFP (a) and UFP (b) at an excitation wavelength of 280 nm. FIG. 7B shows the fluorescence spectrum of UFP at different excitation wavelengths. The a to g are for 370, 320, 330, 340, 360, 350 and 365nm, respectively.

[42] FIG. 8 shows the effect of UFP on cell viability at different concentrations and at different time intervals. The data were shown as the average + standard deviation (n=3). Asterisk (*) denotes p<0.05.

DETAILED DESCRIPTION OF THE EMBODIMENTS

1 Materials and Methods 1.1 Materials

[43] E.coli DHS, BL21(DE3) competent cells, and vector pETCFP-CI containing

ECFP (enhanced cyan fluorescent protein) gene were purchased from Yingrun

Biotechnologies Inc.(Changsha). pHND vector (containing Hal2 tag) 5! and pET-24a (+) vectors were kept in the laboratory. Restriction endonuclease, Dpnl, PCR-related reagents, and T4 DNA ligase, etc. were purchased from Bao Bioengineering Co., Ltd. (Dalian); IPTG, EDTA, ampicillin, kanamycin, yeast extract, and tryptone were purchased from Ox ford LTD (Hampshire, England); DTT, lysozyme, and Pepstatin A were purchased from Amresco Co.; PMSF and EGTA were purchased from BBI life sciences corporation; Ni-NTA His-Bind Super flow Resin was purchased from

Novagen Co.; PAP Agarose was purchased from Sigma Co.; ultrafiltration device was purchased from Millipore Co. Other biochemical reagents were all analytically pure and purchased from Chinese companies. 1.2 ECFP gene mutation primers

[44] According to the known gene sequence, primers were designed by using primer premier 5.0 and synthesized by SBS Gene tech Co. Ltd.( Shanghai), the primers used were shown in Table 1.

Table 1 List of primers in this study

Primers (5°-3’) Nucleotide sequence

F46L-F GACCCTGAAGCTGATCTGCACCACCG

F46L-R CGGTGGTGCAGATCAGCTTCAGGGTC

T65Q-W66F-F GTGACCACCCTGCAGTTTGGCGTGCAGTGC

T65Q-W66F-R GAAGCACTGCACGCCAAACTGCAGGGTGGTCACGAG

Q69L-F GTTTGGCGTGCTGTGCTTCAGCC

Q69L-R GGCTGAAGCACAGCACGCCAAAC

Y145G-H148S-F GCTGGAGTACAACGGCATCAGCAGCAACGTCTATATCACC

Y145G-H148S-R GGTGATATAGACGTTGCTGCTGATGCCGTTGTACTCCAGC

TTG

T203V-F CCACTACCTGAGCGTGCAGTCCGCC

T203V-R GCTCAGGGCGGACTGCACGCTCAGGTAGTGGTTG

Note: Underlined were mutation sites. 1.3 Methods 1.3.1 Site-directed mutation of ECFP gene

[45] The pETCFP-CI was used as a template, the mutation primers listed in Table 1 were used for PCR site-directed mutation as described in the literature !!°!. After the

PCR product was digested with Dp# I (final concentration of 1 U/uL) at 37 °C for 3 h, the product was transformed into DHSa by a heat shock method. The positive bacteria were selected and harbored vectors were sequenced to obtain gene of UFP with mutation of F46L, T65Q, W66F, Q69L, Y145G, H148S and T203V. 1.3.2 Construction of UFP expression vector

[46] UFP fragment was obtained from the confirmed vector by double enzyme digestion (BamH I, EcoR T). The expression vector pET-24a and pHND were subjected to corresponding double enzyme digestion to obtain a linear vector. UFP fragment and the linear vectors were ligated overnight at 16 °C, the ligation product was transformed into BL21(DE3) to obtain pET-24a-UFP and pHND-UFP expression strains. 1.3.3 Analysis of the UV resistance ability of E. coli expressing UFP

[47] A single colony of pET-24a-RFP and pET-24a-UFP were selected and placed into a test tube containing 3 mL of culture medium and cultured overnight at 37°C and at 220 rpm, the cultures were separately transferred to two flasks containing 100 mL liquid medium for amplifying to OD = 0.6, IPTG was added into one flask to a final concentration of 0.5 mM (IPTG was not added into the other flask, which culture was used as a control group), the protein expression was induced for 2 h, the cell pellet was sampled and diluted to an ODso of 0.55~0.65, and then was diluted to 1000 bacteria per mL. 100 pL of diluted bacterial culture was taken and spread on the plate, and then irradiated by ultraviolet (UVB, power 15-20 W, irradiation distance is 56 cm) for 0 5, 10s5,20s5, 305, 405, 50 s and 60 s, and left in the incubator overnight at 37 °C.

Colonies were counted, and survival rates were calculated. 1.3.4 Expression and purification of protein

[48] A single colony of the pHND-UFP expression strain was picked and placed in a test tube containing 3 mL of culture medium (with Kanamycin), and cultured overnight at 37 °C and at 220 rpm. The culture was transferred to 500 mL of medium for amplifying the culture. When the ODsoo was 0.4-0.6, IPTG was added to a final concentration of 0.5 mM. After inducing for 3 h under the same condition, the cell pellets were collected for protein purification. The steps of protein purification may be referred to the literature !'3!71. The protein samples obtained by dialysis and purification were concentrated by low-speed centrifuged with a 3 kD ultrafiltration tube. The concentration of Hal2-UFP and UFP protein was determined according to

Bradford method !#8!. 1.3.5 Purification of fluorescent protein by combination of heating and organic solvent extraction

[49] Fluorescent protein has the characteristics of heat resistance and insensitivity to pH and organic solvents. Therefore, to increase the purification efficiency of UFP and improve the feasibility of large-scale production, the purification method to combine heating and organic solvent extraction was explored. First, single colony of pET-24a-UFP expression strain was picked and placed in a test tube containing 3 mL of culture medium and cultured overnight, then the culture was transferred to 500 mL of medium for amplification. The conditions and induction methods were the same as thatin step 1.3.4. After induction for 3 h, the cell pellets were collected, 50 mL of lysis buffer (50 mM Hepes, 0.3 M NaCl, 0.1 mg/mL lysozyme) was added and aspirated repeatedly to suspend the cell pellet, the cells were disrupted (ultrasonic or repeated freezing and thawing) after incubation at 4°C for 30 min, the mixture was centrifuged at 14000xg for 30 min to obtain the supernatant. The supernatant was heated, and the best treatment conditions were explored at different temperatures (55 'C, 60°C, 65 °C, 70°C and 75°C) and different duration time (5 min, 10 min, 20 min and 40 min). The samples were centrifuged at 12000xg for 10 min after heating, the supernatant was taken for protein electrophoresis, the gray level was calculated by using Area Density in the software Vision works, and the optimized temperature and time were selected.

The heat-treated samples were further extracted with organic solvent according to the literature 1 and the samples after extraction were dialyzed to remove residual organic solvents and small molecular impurities, and protein concentration were determined according to the method in step 1.3.4. 1.3.6 Analysis of cytotoxicity

[50] The concentrated proteins were diluted to 50 uM, and the samples were sterilized by filtration with 0.22 um PVDF. The leukemia cell of TL-OML was treated with four protein concentration set at 0.1, 0.5, 1.0 and 5.0 uM in a 96-well plate, and a blank control was provided. The experimental groups and the blank control were cultured at 5% CO: and 37 °C for 24 h, 48 h and 72 h, respectively. 10 uL/well of MTT solution was added to the well plates after culturing for different time intervals. After incubating for 3 h, an equal amount of lysis solution was added to crack the cells, and

ODss5 was determined by microplate reader. Each group of data was recorded, the effects of UFP at different concentrations and time intervals on cell growth were plotted, and the influence of UFP on cell viability was analyzed. 1.3.7 Spectrum analysis [S1] Absorbance spectrums of affinity chromatography purified UFP (74.0 uM) were analyzed using the Scan program of Agilent Cary 4000 UV-Vis-NIR spectrometer from 250 to 550 nm.

[52] The fluorescence spectrum of UFP(4.5 uM) and Hal2-UFP (4.5 uM) excitated by 280 nm were recorded and compared using the Scan program of Agilent Cary Eclipse spectrophotometer. The fluorescence spectrum of UFP with different excitation wavelengths (320 nm, 330 nm, 340 nm, 350 nm, 360 nm, 365 nm and 370 nm) was also analyzed. 2 Results and analysis 2.1 Results of protein purification

[53] According to the method of reference !!5l, the fusion protein Hal2-UFP was purified by a PAP agarose column, and the fusion protein was enzymatic digested by

HRV 3C protease, the Hal2 tag in the digested sample was removed by flow through the PAP agarose column again to obtain the final UFP, and the purification results were shown in FIG. 2.

[54] Although UFP with a certain purity and content can be obtained by one step affinity chromatography purification, in large-scale practical applications, there are disadvantages such as complex operation, high cost and long cycle. In order to improve the purification efficiency for UFP, the reported method for extracting fluorescent protein with organic solvent *l was used. Although this method has the advantages of short cycle and simple operation, the purity of the purified sample is limited and further punfication is required (FIG. 3, band 5). Fluorescent protein is thermally stable, therefore, the conditions for UFP purification from the supernatant at different temperatures and different times had been explored. The results show that the treatment at 70 °C for 10 min has better effects. The method for purifying high-purity

UFP can established by combining heating treatment with organic solvent extraction (FIG. 3, band 8), which is also suitable for the purification of other fluorescent proteins (FIG. 4, Table 2). In addition, the purified sample contains residual organic solvents and other small molecule impurities which need to be removed by dialysis or ultrafiltration.

Table 2 Purification of different fluorescent proteins by combination of heating and organic solvent extraction “Fluorescent Proteins before Proteins after Purity (%) protein treatment (mg)? purification (mg)? “GFP ss6 OIB

CFP 4.94 0.15 93.8

RFP 4.23 0.34 71.8

YFP 5.80 0.21 94.9

UFP 6.20 0.25 94.7

Note: The value is the average of at least two independent purification.

a The total protein concentration 1s determined according to the Bradford method. >The purity of the target protein is calculated by calculating the gray level of Area Density with

Vision works. 2.2 UFP expression improves the anti-ultraviolet ability of E. coli

[55] In order to explore the possible protection effects of high level UFP by absorbing

UVB and UVA, UFP was inducing expressed in £. coli, and changes of survival ability of £. coli under ultraviolet irradiation were analyzed. The results in FIG. 5, shows that when the protein is not expressed in £. coli, the survival rate is significantly reduced before 40 seconds of ultraviolet irradiation, and the bacteria does not survive after 60 seconds of irradiation. After the expression of RFP in £. coli, the survival rate of £. coli 1s significantly increased possibly resulted from the absorption of UVB by aromatic amino acids in RFP, and the survival rate is 6.2% after irradiating for 60 s.

The survival rate is further increased after the expression of UFP in £. coli, which indicates that the chromophore of UFP has better UVB absorption ability.

[56] The E. coli harboring UFP and RFP genes were divided into two groups, one group was cultured in presence of IPTG for 2 hours, and the other group was cultured in the absence of IPTG for 2 hours. The samples were diluted and cultured on plates, irradiated with UVB (15-20 W, irradiation distance was 56 cm) for different time period. Survival colonies were counted overnight culture. The data were shown as the average + standard deviation (n=3). 2.3 Spectral analysis of UFP protein

[57] UFP was purified by affinity chromotography with a PAP agarose column, and its absorption capacity was detected by an ultraviolet spectrophotometer. The results show that UFP has absorption capacity between 250 and 400 nm, and has two absorption peaks at 280 and 360 nm, respectively (FIG. 6). The extinction coefficients corresponding to the two peaks are calculated according to Lambert-Beer law: A=gcl (wherein A is the absorbance, £ is the extinction coefficient, c is the concentration of sample, and | is the optical path). Comparison with some sunscreens whose extinction coefficient have been determined, the UFP has higher extinction coefficient than those of the compared sunscreens (Table 3). This result shows that UFP has the general characteristic of the sunscreen and can absorb UVA and UVB with nice efficacy.

Table 3 Extinction coefficient of each sunscreen

Sunscreenname Absorption width mx (nm) Emen(<10°M cm) (nm)

Benzophenone 225-290 252 1.818

Anthranilic acid 280-370 248 (1) 0.682 (Ep 336 (22) 0.464 (©)

Ethylcinnamate 230-305 276 2.11

Menthyl o-aminobenzoate 290-370 248.5 (da) 0.768 (En) 338 (A) 0.537 (€)

Vanillin 250~340 278 (2) 1.04 (Eh) 309 (Â2) 1.06 (£€2)

Coumarin 240-340 274 (hy 1.10 (ED 311 Ow) 0.559 (€) 8-hydroxyquinoline 270~350 240 (A) 3.03 CE) 315 (hw) 0.262 (€3) o-aminobenzoate - 270~370 247 (1) 1.03 (En) benzalkonium bromide 328 (2) 0.526 (£2) quaternary ammonium salt

UFP protein 240-408 280 (An) 3.27 (€) 358 (A) 1.54 (£2)

[58] The fluorescence characteristics of Hal2-UFP fusion protein and UFP were analyzed by fluorescence spectrophotometer. The results show that when UFP and

Hal2-UFP with the same concentration are excited by wavelength of 280 nm, two emission peaks at 325 nm and 436 nm are produced from Hal2-UFP, while only a 435 nm emission peak is produced from UFP (Figure 7A). It is proven that the fluorescence

(300-400 nm) produced from the aromatic amino acid of UFP excited at 280 nm can be absorbed by its own chromophore, and the fluorescence produced from Hal2 in the fusion protein excited at 280 nm cannot be further absorbed by the chromophore because the distance between Hal2 and UFP chromophore is not short enough to meet the FRET requirement 2“ In further analysis of the fluorescence characteristics of

UFP, the emission peaks are all about 425nm when excited with wavelengths of 320-370 nm, indicating that the fluorescence produced by UVA excitation from UFP chromophore has a wavelength greater than 400 nm (FIG. 7B), which has little effect to the skin. 2.4 Analysis of UFP cytotoxicity

[59] In order to analyze the toxicity of UFP, the MTT assay was used to detect the influence of UFP on the growth of cell strain TL-OML. The results show that there is no significant difference in the cell survival rates treated with different concentrations of UFP samples after 24 h and 48 h treatment (P>0.05). However, at the concentration of 5.0 uM, cell growth is inhibited after 72 h treatment, but no inhibition was observed after 24 h and 48 h treatment. (FIG. 8) 3 Discussion and prospective

[60] Fluorescent proteins are proteins that can be excited by a specific wavelength to produce fluorescence, having a molecular mass of about 27 kDa, and forms chromophores by autocatalysis between residues 65-6721. Fluorescent protein has a barrel-like structure and has stable properties, and can resist a variety of denaturants such as some proteases, high concentrations of salt (8 M urea), etc., and is pH-independent and thermally stable (T‚=78 °C). Based on the in-depth study results from the fluorescent protein crystal structures, fluorescent proteins with different fluorescent properties have been obtained by mutations. UFP is produced from CFP by mutation of seven amino acid residues. UFP chromophore absorption peak is in the range of UVA, and the aromatic amino acids in UFP can absorb UVB and release UVA.

Therefore, through resonance energy transfer, aromatic amino acids and UFP chromophore can absorbs UVA and UVB, and release fluorescence at wavelength longer than 400 nm (FIG. 1). In summary, UFP is used to explore the feasibility of using protein as sunscreen to absorb UVA and UVB.

[61] By ultraviolet absorbance spectrum analysis and fluorescence spectrum analysis,

UFP is shown to absorb ultraviolet with wavelength of 250-400 nm, among which ultraviolet from 320 to 400 nm is directly converted into fluorescence of 425 nm.

Comparing the fluorescence produced by UFP and by Hal2-UFP under the excitation at 280 nm, it can be shown that ultraviolet rays of 250~320nm is first converted into fluorescence of about 325 nm, and then converted into fluorescence greater than 400 nm by UFP chromophore. In the energy transforming process described above, the surplus energy is released in the form of heat. Therefore, the effectiveness of UFP on absorbing UVA and UVB is verified. At the same time, the high expression of UFP in

E. coli increased its resistance to UVB, further indicating the feasibility of UFP working as sunscreen. Currently, fluorescent protein purification methods are diverse, such as organic extraction method 19221 three-phase separation 2321! hydrophobic chromatography #*!, etc., but when UFP is actually used as sunscreen, the purification efficiency of these methods needs to be improved. UFP can be preliminarily purified initially by heating treatment, and the purity and yield of UFP are significantly improved after combined with organic solvent extraction. To further clarify the safety of UFP, cytotoxicity experiments are carried out by using the MTT assay. The results show that the protein (<5.0 pM) is non-toxic to TL-OML cells for 72 h treatment, which preliminarily shows the safety of UFP. At the same time, the molecular weight of UFP is about 27 kDa, which is stable in nature and will not penetrate the skin. To sum up, based on the current data, UFP can be used as a biological broad-spectrum sunscreen.

[62] This work lays a good foundation for in-depth discussion and study on protein as sunscreen agent. As a kind of sunscreen, the individual indicators still need to be further determined in accordance with the latest "Hygienic Standard for Cosmetics".

Study and exploration of potential of UFP or this kind of protein to be used in sunscreens will be continued.

REFERENCES: 1. Shimomura O, Johnson F H, Saiga Y. Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea [J]. J

Cell Comp Physiol, 1962, 59(3):223-239. 2. Ormo M, Cubitt A B, Kallio K, et al. Crystal structure of the Aequorea victoria

IO green fluorescent protein [J]. Science, 1996, 273(5280):1392-1395. 3. Patterson G, Day R N, Piston D. Fluorescent protein spectra [J]. J Cell Sci, 2001, 114(Pt 5):837-838. 4. Laurent A D, Assfeld X. Effect of the enhanced cyan fluorescent protein framework on the UV/visible absorption spectra of some chromophores [J]. Interdiscip Sci, 2010, 2(1):38-47. 5. Tomosugi W, Matsuda T, Tani T, et al. An ultramarine fluorescent protein with increased photostability and pH insensitivity [J]. Nat Methods, 2009, 6(5):351-353. 6. Day R N, Davidson M W. The fluorescent protein palette: tools for cellular imaging [J]. Chemical Soc Rev, 2009, 38(10):2887-2921. 7. Matsui A, Umezawa K, Shindo Y, et al. A near-infrared fluorescent calcium probe: a new tool for intracellular multicolour Ca?* imaging [J]. Chem Comm, 2011, 47(37):10407-10409. 8. Huang hongfei, Huang jiong, Shou lu, et al. Research Progress of sunscreen[J].

J Zhejiang Norm Univ(Natural Sciences), 2017, 40(2):206-213. 9. Mturi GJ, Martincigh B S. Photostability of the sunscreening agent 4-tert-butyl-4 '-methoxydibenzoylmethane (avobenzone) in solvents of different polarity and proticity [J]. J Photoch Photobio A:Chemistry, 2008, 200(2/3):410-420. 10. Karlsson I, Hillerstrom L, Stenfeldt A L, et al. Photodegradation of dibenzoylmethanes: potential cause of photocontact allergy to sunscreens [J]. Chem

Res Toxicol, 2009, 22(11):1881-1892. 11. Janjua N R, Kongshoj B, Andersson A M, et al. Sunscreens in human plasma and urine after repeated whole-body topical application [J]. J Eur Acad Dermatol Venereol, 2008, 22(4):456-461. 12. Gonzalez H, Farbrot A, Larko O, et al. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation [J]. Br J Dermatol, 2006, 154(2):337-340. 13. Gulson B, Mccall M, Korsch M, et al. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin [J]. Toxico

Sci, 2010, 118(1): 140-149. 14. Smijs T, Pavel. Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness [J]. Nanotechnol Sci Appl, 2011, 4(1):95-112. 15. Yang Y, Ma J H, Yang Y L, et al. Yeast 3 ',5 bisphosphate nucleotidase: An affinity tag for protein purification [J]. Protein Expr Purif, 2014, 97(2):81-87. 16. LiJ, Li C, Xiao W, et al. Site-directed mutagenesis by combination of homologous recombination and Dpnl digestion of the plasmid template in Escherichia coli [J]. Anal

Biochem, 2008, 373(2):389-391. 17. Sun M, Leyh T S.Channeling in sulfate activating complexes [J]. Biochemistry, 2006, 45(38):11304-113 11. 18. Bradford M M.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding [J]. Anal Biochem, 1976, 72:248-254. 19. Samarkina O N, Popova A G, Gvozdik E Y, et al. Universal and rapid method for purification of GFP-like proteins by the ethanol extraction [J]. Protein Expr Purif, 2009, 65(1):108-113. 20. Muller S M, Galliardt H, Schneider J, et al. Quantification of Forster resonance energy transfer by monitoring sensitized emission in living plant cells [J]. Front Plant

Sci, 2013, 4:413. 21. Craggs T D. Green fluorescent protein: structure, folding and chromophore maturation [J]. Chem Soc Rev, 2009, 38(10):2865-2875. 22. Yakhnin A V, Vinokurov L M, Surin A K, et al. Green fluorescent protein purification by organic extraction [J]. Protein Expr Purif, 1998, 14(3):382-3806. 23. Hekmat D, Maslak D, Freiherr Von Roman M, et al. Non-chromatographic preparative purification of enhanced green fluorescent protein [J]. J Biotechnol, 2015, 194:84-90. 24. Jain S, Singh R, Gupta M N. Purification of recombinant green fluorescent protein by three-phase partitioning [J]. J Chromatogr A, 2004, 1035(1):83-86. 25. Mcrae SR, Brown C L, Bushell G R. Rapid purification of EGFP, EYFP, and

ECFP with high yield and purity [J]. Protein Expr Purif, 2005, 41(1):121-127.

SEQUENCE LISTING

<110> Zhejiang Normal University <120> Ultramarine fluorescent protein, construction method therefor and use thereof in preparation of protein sunscreen agent <130> HKJP202108551 <150> CN202010643785.X <I51> 2020-07-07 <160> 12 <170> Patentln version 3.5 <210> 1 <211> 759 <212> DNA <213> Aequorea victoria <400> 1 atggctagca tgactggtgg acagcaaatg ggtcgcggat ccgtgagcaa gggcgaggag 60 ctgttcaccg gggtggtgce catcctggtc gagctggacg gegacgtaaa cggccacagg 120 ttcagcgtgt ccggcgaggg cgagggcgat gccacctacg gcaagctgac cctgaagctg 180 atctgcacca ccggcaagct gcccgtgccc tggcccaccc tegtgaccac cctgcagttt 240 ggcegtactgt gettcagccg ctaccccgac cacatgaage agcacgactt cttcaagtcc 300 gccatgcceg aaggctacgt ccaggagcgt accatcttct tcaaggacga cggcaactac 360 aagacccgeg ccgaggtgaa gttcgagggc gacaccctgg tgaaccgcat cgagctgaag 420 ggcatcgact tcaaggagga cggcaacatc ctggggcaca agctggagta caacggcatc 480 agcagcaacg tctatatcac cgccgacaag cagaagaacg gcatcaaggc ccacttcaag 540 atccgccaca acatcgagga cggcagcgtg cagctcgccg accactacca gcagaacacc 600 cccatcggcg acggccccgt getgetgcce gacaaccact acctgagegt gcagtccgcc 660 ctgagcaaag accccaacga gaagcgcgat cacatggtcc tgetggagtt cgtgaccgcc 720 gccgggatca ctctcggcat ggacgagctg tacaagtga 759 <210> 2 <211> 252 <212> PRT <213> Artificial Sequence <220> <223> modified sequence derived from Aequorea victoria <400> 2

Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg Gly Ser Val Ser 1 5 10 15

Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu 20 25 30

Asp Gly Asp Val Asn Gly His Arg Phe Ser Val Ser Gly Glu Gly Glu 35 40 45

Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Leu Ile Cys Thr Thr 50 55 60

Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Gln Phe 65 70 75 80

Gly Val Leu Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp 85 90 95

Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile 100 105 110

Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe

115 120 125

Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe 130 135 140

Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Gly Ile 145 150 155 160

Ser Ser Asn Val Tyr Ile Thr Ala Asp Lys Gln Lys Asn Gly Ile Lys 165 170 175

Ala His Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu 180 185 190

Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu 195 200 205

Leu Pro Asp Asn His Tyr Leu Ser Val Gln Ser Ala Leu Ser Lys Asp 210 215 220

Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala 225 230 235 240

Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys 245 250

<210> 3 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> F46L-F <400> 3 gaccctgaag ctgatctgca ccaccg 26 <210> 4 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> F46L-R <400> 4 cggtggtgca gatcagcttc agggtc 26

<210> 5 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> T65Q-W66F-F <400> 5 gtgaccaccc tgcagtttgg cgtgcagtgc 30 <210> 6 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> T65Q-WO66F-R <400> 6 gaagcactgc acgccaaact gcagggtggt cacgag 36

<210> 7 <211> 23 <212> DNA <213> Artificial Sequence

<220> <223> Q69L-F <400> 7 stttggcgtg ctgtgcttea goc 23 <210> 8

<211> 23 <212> DNA <213> Artificial Sequence <220>

<223> Q69L-R <400> 8 ggctgaagca cagcacgcca aac 23

<210> 9 <211> 40 <212> DNA

<213> Artificial Sequence <220> <223> Y145G-H148S-F

<400> 9 gctggagtac aacggcatca gcagcaacgt ctatatcacc 40 <210> 10 <211> 43 <212> DNA <213> Artificial Sequence <220> <223> Y145G-H148S-R <400> 10 ggtgatatag acgttgetge tgatgeogtt gtactccagc ttg 43

<210> 11 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> T203V-F <400> 11 ccactacctg agcgtgcagt ccgcC 25 <210> 12

<211> 34 <212> DNA <213> Artificial Sequence <220> <223> T203V-R <400> 12 gctcagggcg gactgcacgc tcaggtagtg gttg 34

SEQLTXT

SEQUENCE LISTING

<110> Zhejiang Normal University <120> Ultramarine fluorescent protein, construction method therefor and use thereof in preparation of protein sunscreen agent <130> HKJIP202108551 <150> CN202010643785.X <151> 2020-07-07 <160> 12 <170> PatentIn version 3.5 <210> 1 <211> 759 <212> DNA <213> Aequorea victoria <400> 1 atggctagca tgactggtgg acagcaaatg ggtcgcggat ccgtgagcaa gggcgaggag 60 ctgttcaccg gggtggtgcc catcctggtc gagctggacg gcgacgtaaa Cggccacagg 120 ttcagcgtgt ccggcgaggg cgagggcgat gccacctacg gcaagctgac cctgaagctg 180 atctgcacca ccggcaagct gcccgtgccc tggcccaccc tcgtgaccac cctgcagttt 240 ggcgtgctgt gcttcagccg ctaccccgac cacatgaagc agcacgactt cttcaagtcc 300 gccatgcccg aaggctacgt ccaggagcgt accatcttct tcaaggacga cggcaactac 360 aagacccgcg ccgaggtgaa gttcgagggc gacaccctgg tgaaccgcat cgagctgaag 420 ggcatcgact tcaaggagga cggcaacatc ctggggcaca agctggagta caacggcatc 480 agcagcaacg tctatatcac cgccgacaag cagaagaacg gcatcaaggc ccacttcaag 540 atccgccaca acatcgagga cggcagcgtg cagctcgccg accactacca gcagaacacc 600 cccatcggcg acggccccgt gctgctgccc gacaaccact acctgagcgt gcagtccgcc 660 ctgagcaaag accccaacga gaagcgcgat cacatggtcc tgctggagtt cgtgaccgcc 720 gccgggatca ctctcggcat ggacgagctg tacaagtga 759 <210> 2 <211> 252 <212> PRT

Pagina 1

SEQLTXT

<213> Artificial Sequence <220> <223> modified sequence derived from Aequorea victoria <400> 2

Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg Gly Ser Val Ser 1 5 10 15

Lys Gly Glu Glu Leu Phe Thr Gly Val Val Pro Ile Leu Val Glu Leu

Asp Gly Asp Val Asn Gly His Arg Phe Ser Val Ser Gly Glu Gly Glu

Gly Asp Ala Thr Tyr Gly Lys Leu Thr Leu Lys Leu Ile Cys Thr Thr 60

Gly Lys Leu Pro Val Pro Trp Pro Thr Leu Val Thr Thr Leu Gln Phe 65 70 75 80

Gly Val Leu Cys Phe Ser Arg Tyr Pro Asp His Met Lys Gln His Asp 85 90 95

Phe Phe Lys Ser Ala Met Pro Glu Gly Tyr Val Gln Glu Arg Thr Ile 100 105 110

Phe Phe Lys Asp Asp Gly Asn Tyr Lys Thr Arg Ala Glu Val Lys Phe 115 120 125

Glu Gly Asp Thr Leu Val Asn Arg Ile Glu Leu Lys Gly Ile Asp Phe 130 135 140

Lys Glu Asp Gly Asn Ile Leu Gly His Lys Leu Glu Tyr Asn Gly Ile 145 150 155 160

Ser Ser Asn Val Tyr Ile Thr Ala Asp Lys Gln Lys Asn Gly Ile Lys 165 170 175

Ala His Phe Lys Ile Arg His Asn Ile Glu Asp Gly Ser Val Gln Leu

Pagina 2

SEQLTXT

180 185 190

Ala Asp His Tyr Gln Gln Asn Thr Pro Ile Gly Asp Gly Pro Val Leu 195 200 205

Leu Pro Asp Asn His Tyr Leu Ser Val Gln Ser Ala Leu Ser Lys Asp 210 215 220

Pro Asn Glu Lys Arg Asp His Met Val Leu Leu Glu Phe Val Thr Ala 225 230 235 240

Ala Gly Ile Thr Leu Gly Met Asp Glu Leu Tyr Lys 245 250 <2105 3 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> F46L-F <400> 3 gaccctgaag ctgatctgca ccaccg 26 <2105 4 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> F46L-R <400> 4 cggtggtgca gatcagcttc agggtc 26 <210>5 5 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> T65Q-W66F-F <400> 5

Pagina 3

SEQLTXT gtgaccaccc tgcagtttgg cgtgcagtgc 30 <210> 6 <211> 36 <212> DNA <213> Artificial Sequence <220> <223> T65Q-W66F-R <400> 6 gaagcactgc acgccaaact gcagggtggt cacgag 36 <210> 7 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Q69L-F <400> 7 gtttggcgtg ctgtgcttca gcc 23 <210> 8 <211> 23 <212> DNA <213> Artificial Sequence <220> <223> Q69L-R <400> 8 ggctgaagca cagcacgcca aac 23 <210> 9 <211> 40 <212> DNA <213> Artificial Sequence <220> <223> Y145G-H148S-F <400> 9 gctggagtac aacggcatca gcagcaacgt ctatatcacc 40 <210> 10

Pagina 4

SEQLTXT

<211> 43 <212> DNA <213> Artificial Sequence <220> <223> Y145G-H148S-R <400> 10 ggtgatatag acgttgctgc tgatgccgtt gtactccagc ttg 43 <210> 11 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> T203V-F <400> 11 ccactacctg agcgtgcagt ccgcc 25 <210> 12 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> T203V-R <400> 12 gctcagggcg gactgcacgc tcaggtagtg gttg 34

Pagina 5

Claims (10)

Conclusions l. Ultramarine fluorescent protein (UFP), wherein the ultramarine fluorescent protein is a protein selected from (a) and (b): (a) a protein consisting of an amino acid sequence set forth in SEQ ID: NO. 2; (b) a protein derived from (a) by substitution, deletion or addition of one or more amino acids in the amino acid sequence of (a) and having activity of the ultramarine fluorescent protein. A gene encoding the ultramarine fluorescent protein according to claim 1. The gene according to claim 2, wherein the gene has a nucleotide sequence set out in SEQ ID: NOI. A vector containing the gene according to claim 2 or 3. A transformant comprising the vector of claim 4. A method for constructing the ultramarine fluorescent protein according to claim 1, comprising: 1) obtaining DNA molecules by site-directed PCR mutagenesis: performing site-directed PCR mutagenesis by means of mutation primers based on at F46L, T65Q, W66F, Q69L, Y145G, H148S and T203 V sites, with pETCFP-CI as a template; 2) transforming the obtained DNA molecules into E. coli DHSa, and obtaining the gene mutated UFP after bacterial selection and sequencing; 3) doubly digesting with enzymes pETUFP-CI, and expression vectors pET-24a and pHND using restriction enzymes BamH1/EcoR1, respectively, and then ligating to form a pET-24a-UFP vector and a pHND-UFP expression vector for UFP- construct expression; 4) transforming a mutated plasmid into BL21(DE3), inoculating a bacterial culture grown overnight in a liquid medium, and collecting the bacterial pellets; 5) taking a lysis buffer, suspending the bacterial pellet in the lysis buffer, breaking the bacteria by ultrasonication in an ice bath after being well suspended, performing centrifugation and collecting a supernatant; 6) heating the supernatant, extracting it with an organic solvent, and then dialyzing the supernatant to remove impurities, concentrating the protein by low speed centrifugation in a 3kD ultrafiltration tube, determining the concentration of the UFP by a Bradford method. The method of claim 6, wherein the sequence of the mutation primer for PCR in step 1) is as follows: F46L-F: GACCCTGAAGCTGATCTGCACCACCG F46L-R: CGGTGGTGCAGATCAGCTTCAGGGTC T65Q-W66F-F: GTGACCACCCTGCAGTTTGGCGTGCAGTGC T65Q-W66F-R: GAAGCACTGCAGCCAAACTGC AGGTGGTCACGAG Q69L-F : GTTTGGCGTGCTGTGCTTCAGCC Q69L-R: GGCTGAAGCACAGCACGCCAAAC Y145G-H148S-F: GCTGGAGTACAACGGCATCAGCAGCAACGTCTATATCACC Y145G-H148S-R: GGTGATATAGACGTTGCTGCTGATGCCGTTGTACTCCAGCTTG T203V-F: CCACTACCTGAGCGTGCAGTCCG CC T203V-R: GCTCAGGGCGGACTGCACGCTCAGGTAGTGGTTG. The mutation primer sequence used in claim 4, wherein the sequence of the mutation primer for PCR is as follows: F46L-F: GACCCTGAAGCTGATCTGCACCACCG F46L-R: CGGTGGTGCAGATCAGCTTCAGGGTC T65Q-W66F-F: GTGACCACCCTGCAGTTTGGCGTGCAGTGC T65Q-W66F-R: GAAGCACTGCAGCCAA ACTGCAGGGTGGTCACGAG Q69L-F: GTTTGGCGTGCTGTGCTTCAGCC Q69L-R: GGCTGAAGCACAGCACGCCAAAC Y145G-H148S-F: GCTGGAGTACAACGGCATCAGCAGCAACGTCTATATCACC Y145G-H148S-R: GGTGATATAGACGTTGCTGCTGATGCCGTGTACTCCAGCTTG T203V-F: CCACTACCTGA GGCGTGCAGTCCGCC T203V-R: GCTCAGGGCGGACTGCACGCTCAGGTAGTGGTTG. Use of the ultramarine fluorescent protein according to claim 1 in preparation of protein for sunscreen. A protein sunscreen comprising the ultramarine fluorescent protein of claim 1.